-
Vaccines, Blood & Biologics
-
FDA Workshop on Testing for Malarial Infections in Blood Donors
- Issue Summary
- Panel/Roundtable Discussions
- Transcripts (PDF - 423 KB)
Acknowledgements
Jerry Holmberg, OPHS, DHHS
Tom McCutchan, NIAID
CDC Colleagues
DOD Colleagues
AABB members
Jennifer Scharpf, CBER
Rhonda Dawson, CBER
Olga Maximova, CBER
Babita Mahajan, CBER
David Asher, CBER
Program committee members
-
Presentations
- FDA Workshop on Testing for Malarial Infections in Blood Donors - Overview & Topics for Discussion
Hira Nakhasi, PhD - Global Problem of Malaria, Biology of Malaria Parasites and Implications for Transfusion-Transmitted Malaria and Detection Methods
Sanjai Kumar, PhD - Current Deferral Policies to Reduce the Risk of Transfusion-Transmitted Malaria and their Impact on Donor Availability
Alan E. Williams - UK experience regarding malaria antibody tests and their contribution to blood safety
Professor PL Chiodini - Malaria in the United States military and its implications for the safety of the blood supply?
Christian F. Ockenhouse MD, PhD - Enhancing US Blood Availability by Testing for Plasmodium spp. Infection
David A. Leiby, PhD - Antigen/Antibody Detection Assays for Malaria
Freddie M. Poole - CDC Experience with Laboratory Tests Used to Investigate Incidents of Transfusion-Transmitted Malaria
Marianna Wilson - Traveler's malaria, locally-transmitted malaria, and transfusion-transmitted malaria in the United States
Monica E. Parise, MD - Malaria antibody test development
Nigel Appleton - Malaria donor deferral policy in France: French experience with malaria antibody screening
Olivier GARRAUD; Marie-Hélène ELGHOUZZI; Azzedine ASSAL; Bertrand PELLETIER; Josiane RELAVE; Georges ANDREU - Prospects for DNA-Based Tests to Detect Malaria Infections
Sanjai Kumar, PhD - Risks versus benefits related to the possible implementation of a malaria blood-screening test
Steve Anderson - Issues with Malaria Screening in the US
Susan L. Stramer, PhD
-
-
-

